New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - sulindac 200mg; sulindac 200mg - tablet - 200 mg - active: sulindac 200mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate active: sulindac 200mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate - aclin is indicated for acute or long-term use in the treatment of the following: · osteoarthritis · rheumatoid arthritis · ankylosing spondylitis · periarticular diseases such as acute painful shoulder (acute subacromial bursitis/supraspinatus tendonitis) and tenosynovitis · acute gouty arthritis · painful low back syndrome (low back pain, commonly referred to as lumbago).

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amoxicillin trihydrate 286.98mg equivalent to amoxycillin 250 mg - capsule - 250 mg - active: amoxicillin trihydrate 286.98mg equivalent to amoxycillin 250 mg excipient: allura red ac   brilliant blue fcf   colloidal silicon dioxide croscarmellose sodium gelatin phloxine b quinoline yellow stearic acid sunset yellow fcf titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amoxicillin trihydrate 573.96mg equivalent to amoxycillin 500 mg - capsule - 500 mg - active: amoxicillin trihydrate 573.96mg equivalent to amoxycillin 500 mg excipient: allura red ac   brilliant blue fcf   colloidal silicon dioxide croscarmellose sodium gelatin phloxine b quinoline yellow stearic acid sunset yellow fcf titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - amitriptyline hydrochloride 25mg;  ;  ;   - film coated tablet - 25 mg - active: amitriptyline hydrochloride 25mg       excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   quinoline yellow titanium dioxide - for the treatment of depression.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - amitriptyline hydrochloride 50mg;  ;  ;  ; amitriptyline hydrochloride 50mg - film coated tablet - 50 mg - active: amitriptyline hydrochloride 50mg       excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide red lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   quinoline yellow titanium dioxide active: amitriptyline hydrochloride 50mg excipient: colloidal silicon dioxide crospovidone hypromellose indigo carmine aluminium lake lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   sunset yellow fcf titanium dioxide - for the treatment of depression.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - hydrochlorothiazide 12.5mg; losartan potassium 50mg;   - film coated tablet - 50mg/12.5mg - active: hydrochlorothiazide 12.5mg losartan potassium 50mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc purified water   quinoline yellow starch titanium dioxide - for the treatment of hypertension, for patients in whom combination therapy is appropriate

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: calcium carbonate colloidal silicon dioxide gelatin lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer microcrystalline cellulose povidone   purified talc   quinoline yellow silicon sodium starch glycolate starch sucrose

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - diltiazem hydrochloride 60mg - film coated tablet - 60 mg - active: diltiazem hydrochloride 60mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate methyl hydroxybenzoate microcrystalline cellulose opadry quinoline yellow sunset yellow fcf - patients with moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - warfarin sodium 1mg - tablet - 1 mg - active: warfarin sodium 1mg excipient: amaranth lactose magnesium stearate maize starch quinoline yellow stearic acid - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, thromboembolism associated with atrial fibrillation, and as an adjunct in the prophylaxis of systemic embolism after myocardial infarction.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - warfarin sodium 5mg - tablet - 5 mg - active: warfarin sodium 5mg excipient: brilliant blue fcf lactose magnesium stearate maize starch quinoline yellow stearic acid - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, thromboembolism associated with atrial fibrillation, and as an adjunct in the prophylaxis of systemic embolism after myocardial infarction.